Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion

Frontiers in Immunology
Flávia CastroMaria José Oliveira

Abstract

Interferon-gamma (IFN-γ) is a pleiotropic molecule with associated antiproliferative, pro-apoptotic and antitumor mechanisms. This effector cytokine, often considered as a major effector of immunity, has been used in the treatment of several diseases, despite its adverse effects. Although broad evidence implicating IFN-γ in tumor immune surveillance, IFN-γ-based therapies undergoing clinical trials have been of limited success. In fact, recent reports suggested that it may also play a protumorigenic role, namely, through IFN-γ signaling insensitivity, downregulation of major histocompatibility complexes, and upregulation of indoleamine 2,3-dioxygenase and of checkpoint inhibitors, as programmed cell-death ligand 1. However, the IFN-γ-mediated responses are still positively associated with patient's survival in several cancers. Consequently, major research efforts are required to understand the immune contexture in which IFN-γ induces its intricate and highly regulated effects in the tumor microenvironment. This review discusses the current knowledge on the pro- and antitumorigenic effects of IFN-γ as part of the complex immune response to cancer, highlighting the relevance to identify IFN-γ responsive patients for the improveme...Continue Reading

References

Sep 1, 1992·European Journal of Immunology·G ValenteG Garotta
Dec 1, 1990·The Journal of Investigative Dermatology·G GrossU Papendick
Dec 1, 1990·The Journal of Investigative Dermatology·I Gresser
Mar 1, 1990·Journal of the American Academy of Dermatology·L EdwardsK A Smiles
Jul 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·D R Johnson, J S Pober
Aug 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·Y ShirayoshiK Ozato
Jul 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M G ToveyM Gigou
Nov 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M S ErnstoffJ M Kirkwood
Apr 15, 1988·International Journal of Cancer. Journal International Du Cancer·E B BröckerC Sorg
Jul 1, 1984·The Journal of Experimental Medicine·A CeladaR D Schreiber
Feb 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·E R Pfefferkorn
Sep 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M WiesenfeldR Pazdur
Sep 1, 1994·Journal of Cellular Biochemistry·F LejeuneP Schmitz
Apr 1, 1993·Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy·W C KoppW J Urba
Mar 1, 1996·European Journal of Immunology·J Girdlestone, M Wing
Jul 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·J F BrombergJ E Darnell
Oct 15, 1996·Proceedings of the National Academy of Sciences of the United States of America·Y NoguchiL J Old
Dec 1, 1996·Journal of Pharmaceutical Sciences·Z Zhao, K W Leong
Jun 26, 1997·Nature·R StarrD J Hilton

❮ Previous
Next ❯

Citations

Aug 4, 2018·Frontiers in Microbiology·Guangyun TanGenhong Cheng
Aug 24, 2019·Frontiers in Immunology·Antonio MarchiniJean Rommelaere
Aug 30, 2019·Current Opinion in Rheumatology·Laure GallayBénédicte Chazaud
Jun 23, 2020·Nature Cancer·Mirjam E HoekstraTon N M Schumacher
Aug 18, 2020·Virchows Archiv : an International Journal of Pathology·Taishi TakaharaShigeo Nakamura
Mar 5, 2019·Archives of Pharmacal Research·Young-Ho Lee, Chan Hyuk Kim
Aug 4, 2019·Cancer Immunology, Immunotherapy : CII·Michael FriedrichBarbara Seliger
Nov 12, 2019·The Journal of Clinical Investigation·Mahnaz SahraeiYajaira Suárez
Jan 29, 2020·Proceedings of the National Academy of Sciences of the United States of America·Felix KlattClaus-D Kuhn
Jan 11, 2020·Frontiers in Immunology·Arden G Vanderwall, Erin D Milligan
Dec 19, 2019·Scientific Reports·Gebhard SchratterWolfgang Schreibmayer
May 10, 2020·Molecular Oncology·Relinde I Y LieverseLudwig J Dubois
Mar 25, 2020·International Journal of Molecular Sciences·Xiang SongYong Zhao
Jul 2, 2020·American Journal of Respiratory Cell and Molecular Biology·Andrew D PriggeKaren M Ridge
Jul 2, 2020·OncoTargets and Therapy·Shuya LiuJingbo Wu
Jul 11, 2018·British Journal of Cancer·Helena A SterleVanina A Medina
Oct 19, 2019·Clinical & Translational Immunology·Mathilde RaverdeauLydia Lynch
May 23, 2019·Journal of Experimental & Clinical Cancer Research : CR·Lei JiangPei-Wu Yu
Jan 18, 2020·Cancers·Taylor T ChrisikosStephanie S Watowich
Feb 11, 2020·Frontiers in Immunology·Morgan E Parker, Maria Ciofani
Aug 14, 2019·Investigational New Drugs·Sadal RefaeEsma Saada-Bouzid
Feb 18, 2020·Frontiers in Immunology·Nicola TuminoLorenzo Moretta
Jan 16, 2020·Cancers·Anzhelika KarjalainenMathias Müller

❮ Previous
Next ❯

Methods Mentioned

BETA
ubiquitination
xenografts

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Related Papers

Cancer Letters
Rozita RoshaniThorsten Hagemann
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Eric K RingGregory K Friedman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
M Raza Zaidi, Glenn Merlino
© 2022 Meta ULC. All rights reserved